Drug Profile
Vascular endothelial growth factors
Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Nonindustrial source; R&D Systems
- Class
- Mechanism of Action Angiogenesis inducing agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Ischaemic heart disorders
Most Recent Events
- 18 Jun 1999 New profile
- 18 Jun 1999 Preclinical development for Ischaemic heart disorders in France (Unknown route)
- 18 Jun 1999 Preclinical development for Ischaemic heart disorders in Italy (Unknown route)